TrialClinical pharmacokinetics2024

Dosing of Convalescent Plasma and Hyperimmune Anti-SARS-CoV-2 Immunoglobulins: A Phase I/II Dose-Finding Study.

Sammy Huygens et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.